BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29780384)

  • 1. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
    Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
    Front Immunol; 2018; 9():912. PubMed ID: 29780384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.
    Chikata T; Paes W; Akahoshi T; Partridge T; Murakoshi H; Gatanaga H; Ternette N; Oka S; Borrow P; Takiguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-E-restricted, Gag-specific CD8
    Yang H; Rei M; Brackenridge S; Brenna E; Sun H; Abdulhaqq S; Liu MKP; Ma W; Kurupati P; Xu X; Cerundolo V; Jenkins E; Davis SJ; Sacha JB; Früh K; Picker LJ; Borrow P; Gillespie GM; McMichael AJ
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33766848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
    Bansal A; Gehre MN; Qin K; Sterrett S; Ali A; Dang Y; Abraham S; Costanzo MC; Venegas LA; Tang J; Manjunath N; Brockman MA; Yang OO; Kan-Mitchell J; Goepfert PA
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of proteasome-catalyzed peptide
    Paes W; Leonov G; Partridge T; Chikata T; Murakoshi H; Frangou A; Brackenridge S; Nicastri A; Smith AG; Learn GH; Li Y; Parker R; Oka S; Pellegrino P; Williams I; Haynes BF; McMichael AJ; Shaw GM; Hahn BH; Takiguchi M; Ternette N; Borrow P
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24748-24759. PubMed ID: 31748275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
    Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
    J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.
    Weisbrod L; Capriotti L; Hofmann M; Spieler V; Dersch H; Voedisch B; Schmidt P; Knake S
    Front Immunol; 2024; 15():1386160. PubMed ID: 38779658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.
    Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO
    J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
    Chikata T; Paes W; Kuse N; Partridge T; Gatanaga H; Zhang Y; Kuroki K; Maenaka K; Ternette N; Oka S; Borrow P; Takiguchi M
    J Virol; 2022 May; 96(10):e0043222. PubMed ID: 35475667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
    Ternette N; Yang H; Partridge T; Llano A; Cedeño S; Fischer R; Charles PD; Dudek NL; Mothe B; Crespo M; Fischer WM; Korber BT; Nielsen M; Borrow P; Purcell AW; Brander C; Dorrell L; Kessler BM; Hanke T
    Eur J Immunol; 2016 Jan; 46(1):60-9. PubMed ID: 26467324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host genotype and time dependent antigen presentation of viral peptides: predictions from theory.
    Eccleston RC; Coveney PV; Dalchau N
    Sci Rep; 2017 Oct; 7(1):14367. PubMed ID: 29084996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
    PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.
    Oyarzun P; Ellis JJ; Gonzalez-Galarza FF; Jones AR; Middleton D; Boden M; Kobe B
    Vaccine; 2015 Mar; 33(10):1267-73. PubMed ID: 25629524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approach to recognition of predicted HIV-1 Gag B3501-restricted CD8 T-cell epitopes by HLA-B3501(+) patients: confirmation by quantitative ELISpot analyses and characterisation using multimers.
    Westrop SJ; Grageda N; Imami N
    J Immunol Methods; 2009 Feb; 341(1-2):76-85. PubMed ID: 19056394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles.
    Hensen L; Illing PT; Rowntree LC; Davies J; Miller A; Tong SYC; Habel JR; van de Sandt CE; Flanagan KL; Purcell AW; Kedzierska K; Clemens EB
    Front Immunol; 2022; 13():812393. PubMed ID: 35603215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of HIV-1 to human leukocyte antigen class I.
    Kawashima Y; Pfafferott K; Frater J; Matthews P; Payne R; Addo M; Gatanaga H; Fujiwara M; Hachiya A; Koizumi H; Kuse N; Oka S; Duda A; Prendergast A; Crawford H; Leslie A; Brumme Z; Brumme C; Allen T; Brander C; Kaslow R; Tang J; Hunter E; Allen S; Mulenga J; Branch S; Roach T; John M; Mallal S; Ogwu A; Shapiro R; Prado JG; Fidler S; Weber J; Pybus OG; Klenerman P; Ndung'u T; Phillips R; Heckerman D; Harrigan PR; Walker BD; Takiguchi M; Goulder P
    Nature; 2009 Apr; 458(7238):641-5. PubMed ID: 19242411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple T-cell epitopes overlap positively-selected residues in the p1 spacer protein of HIV-1 gag.
    Semeniuk CA; McKinnon L; Peters HO; Gubbins M; Mao X; Ball TB; Luo M; Plummer FA
    AIDS; 2009 Apr; 23(7):771-7. PubMed ID: 19287301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.